Search

Your search keyword '"Bonavita, Simona"' showing total 945 results

Search Constraints

Start Over You searched for: Author "Bonavita, Simona" Remove constraint Author: "Bonavita, Simona"
945 results on '"Bonavita, Simona"'

Search Results

54. Efficacy of different rituximab therapeutic strategies in patients with neuromyelitis optica spectrum disorders

55. Cardiovascular autonomic individual profile of relapsing-remitting multiple sclerosis patients and risk of extending cardiac monitoring after first dose fingolimod

56. COVID-19 Severity in Multiple Sclerosis: Putting Data Into Context

57. Extending the Interval of Natalizumab Dosing: Is Efficacy Preserved?

61. Cost-Analysis of Telemedicine Interventions Compared with Traditional Care in the Management of Chronic Neurological Diseases: A Systematic Review.

66. Correction to: Disability assessment using Google Maps

69. Validation of an iPad version of the Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS) (P3-3.010)

71. Sexual Dysfunction in People with Multiple Sclerosis: The Role of Disease Severity, Illness Perception, and Depression

73. Epidemiological and Immune Profile Analysis of Italian Subjects with Endometriosis and Multiple Sclerosis

74. Cladribine vs other drugs in MS: Merging randomized trial with real-life data

77. Repetitive Transcranial Magnetic Stimulation (rTMS) in Mild Cognitive Impairment: Effects on Cognitive Functions—A Systematic Review.

78. Pain, quality of life, and religiosity in people with multiple sclerosis

83. Alemtuzumab-Related Lymphocyte Subset Dynamics and Disease Activity or Autoimmune Adverse Events: Real-World Evidence

84. Long-Term Neuromodulatory Effects of Repetitive Transcranial Magnetic Stimulation (rTMS) on Plasmatic Matrix Metalloproteinases (MMPs) Levels and Visuospatial Abilities in Mild Cognitive Impairment (MCI)

87. Reduced Clinical Connectome Fingerprinting in Multiple Sclerosis Predicts Fatigue Severity

89. Editorial: Disease modifying therapies in multiple sclerosis

93. Unmet needs and gaps in the identification of secondary progression in multiple sclerosis: a Southern Italy healthcare professionals’ perspective

94. Clinical effectiveness of different natalizumab interval dosing schedules in a large Italian population of patients with multiple sclerosis

97. Validation of an iPad version of the Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS)

100. Breakthrough SARS-CoV-2 infections in MS patients on disease-modifying therapies

Catalog

Books, media, physical & digital resources